Suppr超能文献

欧洲合理用药当前障碍映射(CORUM):现状与潜在解决方案

Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions.

作者信息

Gad Mohamed, Salem Ahmed, Oortwijn Wija, Hill Ruaraidh, Godman Brian

机构信息

Global Health and Development Group, Imperial College London, London, United Kingdom.

Real World Evidence Solutions, IQVIA, Zaventem, Belgium.

出版信息

Front Pharmacol. 2020 Mar 3;11:144. doi: 10.3389/fphar.2020.00144. eCollection 2020.

Abstract

INTRODUCTION

There are increasing concerns regarding the inappropriate use of medicines with expenditure continuing to grow driven by increasing sales in oncology and orphan diseases, enhanced by their emotive nature. As a result, even high income countries are struggling to fund new premium priced medicines. These concerns have resulted in initiatives to better manage the entry of new medicines and enhance the rational use of medicines (RUM). However, there is a need to ascertain the current situation. We sought to address this by developing the Current Obstacles for Rationalizing Use of Medicines in Europe (CORUM) mapping tool to qualitatively investigate the current situation and provide analysis of current views on RUM and interventions among key European payers and their advisers. The findings will be used to provide future guidance.

METHODOLOGY

Descriptive study exploring and identifying perceived gaps to achieving optimal RUM. The CORUM tool was based on the WHO 12 key interventions to promote RUM.

RESULTS

62 participants took part with most respondents believing their country could improve RUM capacity. This included educational initiatives on the use of clinical guidelines (90%) and the inclusion of problem-based pharmacotherapy in undergraduate curricula and for Continued Professional Development. Key challenges included a lack of regular updates of guidelines, exacerbated by limited funding and a lack of follow-up to monitor adherence to agreed guidelines. RUM could also be enhanced by the development of regional formularies as well as implementing Drug and Therapeutic Committees where these are currently limited. There also needs to be greater co-ordination between RUM and Health Technology Assessment activities, with countries learning from each other.

CONCLUSION

There is an urgent need to improve RUM through improved educational and other activities among European countries, with countries learning from each other. This will involve addressing current challenges and we will be following this up.

摘要

引言

随着肿瘤学和罕见病药物销售额的不断增长,因其情感属性加剧了药物支出的持续增加,人们对药物的不当使用愈发担忧。因此,即使是高收入国家也在努力为新的高价药物提供资金。这些担忧促使人们采取举措,以更好地管理新药的引入并加强药物合理使用(RUM)。然而,有必要确定当前的状况。我们试图通过开发欧洲药物合理使用当前障碍(CORUM)映射工具来解决这一问题,以定性研究当前状况,并分析欧洲主要支付方及其顾问对药物合理使用和干预措施的当前看法。研究结果将用于提供未来的指导。

方法

描述性研究,探索并识别实现最佳药物合理使用中存在的认知差距。CORUM工具基于世界卫生组织促进药物合理使用的12项关键干预措施。

结果

62名参与者参与了研究,大多数受访者认为他们的国家可以提高药物合理使用能力。这包括关于临床指南使用的教育举措(90%),以及将基于问题的药物治疗纳入本科课程和继续职业发展中。主要挑战包括指南缺乏定期更新,资金有限和缺乏后续跟进以监测对商定指南的遵守情况加剧了这一问题。通过制定区域药品目录以及在目前有限的地区实施药物与治疗委员会,也可以加强药物合理使用。药物合理使用和卫生技术评估活动之间也需要更好的协调,各国应相互学习。

结论

迫切需要通过在欧洲国家之间改进教育和其他活动来提高药物合理使用,各国应相互学习。这将涉及应对当前的挑战,我们将对此进行跟进。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验